CDH1 and endometrial carcinoma: Further analysis demonstrated that the CDH1 mRNA levels were not significantly changed across the major cancer stages in breast carcinoma (Fig. 2E), colon carcinoma, pancreatic carcinoma, lung carcinoma, and endometrial carcinoma (Supplementary Fig. 1C-F—Additional file 1).